Bausch Health’s Strategic Growth in Latin...

By HEOR Staff Writer

January 8, 2026

Navigating Growth in Latin American Pharmaceuticals In the Latin American pharmaceuticals sector, Bausch Health is strategically expanding its footprint under the leadership of Vic...
CHMP Meeting Highlights: December 2025 Advances in New Medicines Approvals
2025 China Drug Catalog Boosts Access with 114 New Drugs and Innovative Solut...
NICE Approves Seven Digital Cardiac Rehabilitation Technologies for Enhanced ...
GLP-1RAs Psychiatric Care: Transforming Metabolic Management for Psychotropic...
Accelerating Access to Latin America Innovative Therapies Through Collaborati...
Health Investment Returns: Harnessing Health as a Strategic Economic Asset
Weight Loss: Advances in Hormone-Based Obesity Treatments
Beta-Blockers in Heart Attack Recovery: Reevaluating Their Role Based on Rece...
CTX310 Lipid Disorder: Phase 1 Trial Shows Promising LDL and Triglyceride Red...
Eloralintide Obesity Treatment: Phase 2 Trial Reveals Significant Weight Loss...
Addressing GLP-1 Access Inequity: Lessons from HIV/AIDS Mobilization
Insights on GLP-1 Therapy in Bariatric Surgery Patients